Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Bipolar DisorderDepression, Bipolar
Interventions
DRUG

SEROQUEL (quetiapine fumarate) Tablets

Trial Locations (27)

Unknown

Birmingham

Beverly Hills

La Mesa

San Diego

Jacksonville

Orlando

West Palm Beach

Winter Park

Atlanta

Smyrna

Oak Brook

Shreveport

Clementon

Moorestown

New York

Staten Island

Raleigh

Cincinnati

Cleveland

Dayton

Columbia

Memphis

Austin

Salt Lake City

Falls Church

Bellevue

Kirkland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY